Friday, July 31, 2026

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

Coupang Hit With U.S. House Judiciary Committee Subpoena: Is Seoul Discriminating Against U.S. Tech?

Coupang will cooperate with a U.S. investigation into South Korea's digital regulations affecting U.S. companies, amid tariff threats.

British Public Agencies Turn to AI, But Struggle with Data and Costs

The UK leads Europe in AI adoption within the public sector, with 75% using generative AI, despite concerns over data security and costs.

Tag: G-Eazy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.